David Tamang

David Tamang has extensive experience in clinical research and biomarker operations, currently serving as a Clinical Trial Manager at Syndax Pharmaceuticals since February 2017. In this role, David oversees clinical trials, including the SNDX-5613-0700 and SNDX-5613-0705 studies, while previously managing interdisciplinary teams and contributing to biomarker strategy for multiple phases of clinical trials. Prior to Syndax, David worked at Acetylon Pharmaceuticals, where contributions included advancing oncology therapeutics and developing pharmacodynamics assays. Early career experiences include a Research Fellowship at Massachusetts General Hospital focused on inflammatory lung diseases, a Graduate Assistant role at the University of Nevada Reno, and running a small business. David holds a Ph.D. in Cellular Immunology and degrees in Education and Molecular Biology.